Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
Schizophrenia Research and Treatment · 2012
DOI: 10.1155/2012/318535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Research and Treatment, 2012. Verfasst von Eduard Parellada und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinic Schizophrenia Program (PEC), Department of Psychiatry, Hospital Clinic of Barcelona, University of Barcelona, 08036 Barcelona, Catalonia, Spai…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Clinic Schizophrenia Program (PEC), Department of Psychiatry, Hospital Clinic of Barcelona, University of Barcelona, 08036 Barcelona, Catalonia, Spain.
Zitieren
APA
Parellada, E., Velligan, D. I., Emsley, R., & Kissling, W. (2012). Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia. Schizophrenia Research and Treatment. https://doi.org/10.1155/2012/318535
Vancouver
Parellada E, Velligan DI, Emsley R, Kissling W. Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia. Schizophrenia Research and Treatment. 2012. doi:10.1155/2012/318535
BibTeX
@article{Parellada2012,
author = {Parellada, Eduard and Velligan, Dawn I and Emsley, Robin and Kissling, Werner},
title = {Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia},
journal = {Schizophrenia Research and Treatment},
year = {2012},
doi = {10.1155/2012/318535}
}
EUVIMED